Ergoloid (BioDeep_00000169729)

   

human metabolite


代谢物信息卡片


(2R,4R,7R)-N-[(1S,2S,4R,7S)-2-hydroxy-7-methyl-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraene-4-carboxamide

化学式: C29H37N5O5 (535.2794552)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O
InChI: InChI=1S/C29H37N5O5/c1-15(2)28(27(37)34-16(3)26(36)33-10-6-9-23(33)29(34,38)39-28)31-25(35)18-11-20-19-7-5-8-21-24(19)17(13-30-21)12-22(20)32(4)14-18/h5,7-8,13,15-16,18,20,22-23,30,38H,6,9-12,14H2,1-4H3,(H,31,35)/t16-,18+,20+,22+,23-,28+,29-/m0/s1

描述信息

Ergoloid belongs to the class of organic compounds known as ergopeptines. These are ergoline derivatives that contain a tripeptide structure attached to the basic ergoline ring in the same location as the amide group of the lysergic acid derivatives. Ergoloid is considered to be a practically insoluble (in water) and relatively neutral molecule.

同义名列表

6 个代谢物同义名

(2R,4R,7R)-N-[(1S,2S,4R,7S)-2-hydroxy-7-methyl-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraene-4-carboxamide; (2R,4R,7R)-N-[(1S,2S,4R,7S)-2-hydroxy-4-isopropyl-7-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraene-4-carboxamide; (2R,4R,7R)-N-[(1S,2S,4R,7S)-2-Hydroxy-7-methyl-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0²,⁶]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraene-4-carboximidate; (2R,4R,7R)-N-[(1S,2S,4R,7S)-2-Hydroxy-7-methyl-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0,]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0,.0,]hexadeca-1(16),9,12,14-tetraene-4-carboximidate; (6aR,9R,10aR)-N-[(1S,2S,4R,7S)-2-hydroxy-7-methyl-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide; Ergoloid



数据库引用编号

4 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Sui Cheung Man, Kam Wa Chan, Jia-Hong Lu, Siva Sundara Kumar Durairajan, Liang-Feng Liu, Min Li. Systematic review on the efficacy and safety of herbal medicines for vascular dementia. Evidence-based complementary and alternative medicine : eCAM. 2012; 2012(?):426215. doi: 10.1155/2012/426215. [PMID: 22235231]
  • Ming Zheng, Linhai Qu, Yijia Lou. Effects of icariin combined with Panax notoginseng saponins on ischemia reperfusion-induced cognitive impairments related with oxidative stress and CA1 of hippocampal neurons in rat. Phytotherapy research : PTR. 2008 May; 22(5):597-604. doi: 10.1002/ptr.2276. [PMID: 18398927]
  • Jian Chen, Xiaomei Wang, Juan Wang, Guangli Liu, Xing Tang. Evaluation of brain-targeting for the nasal delivery of ergoloid mesylate by the microdialysis method in rats. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 2008 Mar; 68(3):694-700. doi: 10.1016/j.ejpb.2007.08.013. [PMID: 17945473]
  • Beatriz Bicalho, Juliana Marconi Giolo, Sergio Lilla, Gilberto De Nucci. Identification and human pharmacokinetics of dihydroergotoxine metabolites in man: preliminary results. Biopharmaceutics & drug disposition. 2008 Jan; 29(1):17-28. doi: 10.1002/bdd.585. [PMID: 17941060]
  • Wen-Jen Lu, Jin-Ding Huang, Ming-Liang Lai. The effects of ergoloid mesylates and ginkgo biloba on the pharmacokinetics of ticlopidine. Journal of clinical pharmacology. 2006 Jun; 46(6):628-34. doi: 10.1177/0091270006287024. [PMID: 16707409]
  • Ursula Werneke, Trevor Turner, Stefan Priebe. Complementary medicines in psychiatry: review of effectiveness and safety. The British journal of psychiatry : the journal of mental science. 2006 Feb; 188(?):109-21. doi: 10.1192/bjp.188.2.109. [PMID: 16449696]
  • Jun-shan Huang, Qiu-cheng Lin, Rong-zhang Huang. [Clinical study on effect of yuantong capsule in treating vascular dementia]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine. 2003 Nov; 23(11):815-8. doi: ". [PMID: 14666760]
  • A Gomaa, M Eissa, A El-Gebaley. The effect of topically applied vasoactive agents and testosterone versus testosterone in the treatment of erectile dysfunction in aged men with low sexual interest. International journal of impotence research. 2001 Apr; 13(2):93-9. doi: 10.1038/sj.ijir.3900643. [PMID: 11426345]